Group 1 - The core viewpoint of the news is the performance and holdings of the China Europe Medical Innovation Stock A fund, which has shown significant growth in recent months and has a strong portfolio in the healthcare sector [1][3] - As of May 21, 2025, the latest net value of the fund is 1.3071 yuan, reflecting a growth of 2.38%. The fund's one-month return is 13.83%, six-month return is 19.76%, and year-to-date return is 25.71% [1] - The fund's top ten stock holdings account for a total of 75.62%, with notable investments in WuXi AppTec (10.35%), Kelun-Biotech (10.15%), and WuXi Biologics (9.82%) among others [1] Group 2 - The China Europe Medical Innovation Stock A fund was established on February 28, 2019, and as of March 31, 2025, it has a total scale of 4.675 billion yuan [1] - The fund is managed by Guo Lan, who has extensive experience in the investment management field, having held various positions in research and fund management since joining China Europe Fund Management in 2014 [2]
5月21日中欧医疗创新股票A净值增长2.38%，今年来累计上涨25.71%
Sou Hu Cai Jing·2025-05-21 12:00